The new Canadian Cardiovascular Society algorithm for antithrombotic therapy of atrial fibrillation is appropriately based on current epidemiologic data

Affiliations

¹ GLD Health Care Centre, Department of Medicine, University of British Columbia, Vancouver, British Columbia. Electronic address: john.cairns@ubc.ca.
² Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
³ Montreal Heart Institute, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
⁴ Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
⁵ Southlake Regional Health Centre, University of Toronto, Newmarket, Ontario, Canada.

Editorial

John A Cairns et al. Can J Cardiol. 2015 Jan.

. 2015 Jan;31(1):20-3.

doi: 10.1016/j.cjca.2014.11.021. Epub 2014 Nov 26.

¹ GLD Health Care Centre, Department of Medicine, University of British Columbia, Vancouver, British Columbia. Electronic address: john.cairns@ubc.ca.
² Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
³ Montreal Heart Institute, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
⁴ Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
⁵ Southlake Regional Health Centre, University of Toronto, Newmarket, Ontario, Canada.

No abstract available

Comment on

Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".
Lip GY, Nielsen PB, Skjøth F, Rasmussen LH, Larsen TB. Lip GY, et al. Can J Cardiol. 2015 Jan;31(1):24-8. doi: 10.1016/j.cjca.2014.10.018. Epub 2014 Oct 17. Can J Cardiol. 2015. PMID: 25547546